Ashish Nimgaonkar
Company: Glyscend Inc.
Job title: Chief Medical Officer
Seminars:
Panel Discussion & Extended Q&A: Summarising the Progress & Promise of Upcoming MoAs, Understanding Disease Modifying Potential 3:30 pm
day: Conference Day Two
Shedding Light on Gut-Driven Mechanisms for Rethinking Targets in Disease Modification 1:15 pm
Investigating the involvement of gut microbiota in the dysfunction of beta cells and development of insulin resistance Revealing the potential of gut signalling as a means for modifying diseases and identifying specific gut targets informed by insights from bariatric surgery Spearheading the development of innovative gut-targeted polymer therapies aimed at enhancing blood glucose levelsRead more
day: Conference Day Two